Primary Human Coronary Artery Endothelial Cells (ACBRI 377) were initiated from normal human coronary artery.
|
Cell Initiation
These cells were originated using Cell Systems Complete Serum-Free Medium (SF-4Z0-500), and subsequently grown and passaged in Cell Systems Complete Medium (4Z0-500). They are available at Passage 3 [< 12 cumulative population doublings] cryopreserved in Cell Systems Cell Freezing Medium™ (4Z0-705). This vial will initiate a Passage 4 cell culture in a 75cm2 flask. Each vial contains more than 1 x 106 cells.
In addition to cryopreserved vials, these cells also are available in 25cm2 and 75cm2 proliferating cell culture flasks (US domestic market only).
Companion Products
Each vial of cells is shipped with vials of Bac-Off® (antibiotic) and CultureBoost™ (animal derived growth factors) or CultureBoost-R™ (human recombinant growth factors) at no additional cost.
These cells are qualified for use with:
|
|
|
Standard Tests
TEST | RESULTS |
HIV Serologic Test (donor level HIV AB EIA) | Negative |
HIV PCR Test (frozen cell pool by CLIA Licensed Clinical Lab) | Negative |
Test of frozen cells for Mycoplasma spp. (ATCC method by CLIA Licensed Clinical Lab) | Negative |
Miscellaneous Tests
TEST | RESULTS |
Inducible expression of CD 62E (E-Selectin) | > 90% positive by immunofluorescence |
Cytoplasmic VWF / Factor VIII | > 95% positive by immunofluorescence |
Cytoplasmic uptake of Di-I-Ac-LDL | > 95% positive by immunofluorescence |
Citations
- Costa de Carvalho et al. Immunobiology, 2019
- Saamoto et al. J International Medical Research, 2011.
- Jimenez et al. Journal of Thrombosis and Haemostasis, 2005
- Elsevier, 2004
- Jimenez et al. Thrombosis Research, 2003.
- Osada et al. Elsevier, 2002
- " Matsumoto et al. American Journal of Hypertension, 2002
- " Yamamoto et al. American Journal of Hypertension, 2002
- Yang et al. The Journal of Clinical Endocrinology & Metabolism, 2000
- Inoue et al. BBRC, 1998.
- Gupta et al. J Biological Chemistry, 1998.
Cell Systems cells are available for in vitro research purposes only and may not be transferred out of the direct control of the recipient Institution/Agency/Organization. Cell Systems cells may not be genetically altered in any way without prior written permission from Cell Systems. Use of Cell Systems materials (evidenced by placement of any order for product) constitutes knowledge, understanding and binding acceptance of these restrictions on behalf of the recipient Institution/Agency/Organization.
Cell Systems was created to further the knowledge of eukaryotic cell biology through laboratory research, publications and teaching. Cell Systems provides cells and cell culture products to other research entities - public and private.